These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 25024593

  • 1. Modern approach to the clinical management of non-alcoholic fatty liver disease.
    Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F.
    World J Gastroenterol; 2014 Jul 14; 20(26):8341-50. PubMed ID: 25024593
    [Abstract] [Full Text] [Related]

  • 2. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD.
    Djordjevic DB, Zdravkovic M, Nagorni A, Manolis A, Tsioufis C, Lovic D.
    Curr Vasc Pharmacol; 2018 Jul 14; 16(3):228-238. PubMed ID: 28676026
    [Abstract] [Full Text] [Related]

  • 3. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A, Zulli C, de Sio I, Del Prete A, Dallio M, Masarone M, Loguercio C.
    World J Gastroenterol; 2014 Dec 07; 20(45):16841-57. PubMed ID: 25492998
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG, Boutari C, Stavropoulos K, Anagnostis P, Imprialos KP, Doumas M, Karagiannis A.
    Curr Vasc Pharmacol; 2018 Dec 07; 16(3):246-253. PubMed ID: 28676019
    [Abstract] [Full Text] [Related]

  • 16. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S, Lulić D, Štimac D.
    World J Gastroenterol; 2014 Jul 28; 20(28):9330-7. PubMed ID: 25071327
    [Abstract] [Full Text] [Related]

  • 17. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G.
    Transplantation; 2019 Jan 28; 103(1):28-38. PubMed ID: 30300289
    [Abstract] [Full Text] [Related]

  • 18. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K, Imprialos K, Pittaras A, Faselis C, Narayan P, Kokkinos P.
    Curr Vasc Pharmacol; 2018 Jan 28; 16(3):239-245. PubMed ID: 28637408
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.